Heron Therapeutics, Inc. (HRTX)

NCM – Real vaqt narxi. Valyuta: USD

0.35

+0.02 (7.38%)

Bozor ochiq: Aug 12, 2026, 3:11 PM EDT

0.32

-0.00 (-0.99%)

Oldingi bozordan keyin: Aug 11, 2026, 7:58 PM EDT

10.08.2026

Heron Therapeutics, Inc. (HRTX) Q2 2026 Earnings Call Transcript

10.08.2026

Heron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates

Heron Therapeutics (HRTX) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.02 per share a year ago.

10.08.2026

Heron Therapeutics Q2 Earnings Call Highlights

Heron Therapeutics NASDAQ: HRTX reported second-quarter net revenue of $37.7 million, up from $34.7 million in the first quarter and $37.2 million in the comparable prior-year period, while management said sales of its key products came in below its internal expectations.

Videolar

No Data

There is no data to display

Reytinglar oshishi / pasayishi

Ticker	Tashkilot	Reyting o‘zgarishi	Maqsadli narx	Sana
HRTX	H.C. Wainwright	Neutral	undefined >> undefined	August 11th 2026

Heron Therapeutics, Inc. (HRTX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Heron Therapeutics, Inc. (HRTX)

Heron Therapeutics, Inc. (HRTX) Q2 2026 Earnings Call Transcript

Heron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates

Heron Therapeutics Q2 Earnings Call Highlights

Videolar

No Data

Reytinglar oshishi / pasayishi

Heron Therapeutics, Inc. (HRTX) Q2 2026 Earnings Call Transcript

Heron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates

Heron Therapeutics Q2 Earnings Call Highlights

Videolar

No Data

Reytinglar oshishi / pasayishi

Search stocks

Heron Therapeutics, Inc. (HRTX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Heron Therapeutics, Inc. (HRTX)

Heron Therapeutics, Inc. (HRTX) Q2 2026 Earnings Call Transcript

Heron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates

Heron Therapeutics Q2 Earnings Call Highlights

Videolar

No Data

Reytinglar oshishi / pasayishi

Heron Therapeutics, Inc. (HRTX) Q2 2026 Earnings Call Transcript

Heron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates

Heron Therapeutics Q2 Earnings Call Highlights

Videolar

No Data

Reytinglar oshishi / pasayishi